Biofrontera AG | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,933.60
9,236.20
4,689.60
16,503.00
11,183.00
19,451
Total Accounts Receivable
677.70
371.10
926.80
1,657.00
1,613.00
3,450
Inventories
1,585.20
1,393.50
1,533.60
3,646.30
3,733.00
3,177
Other Current Assets
771.10
90.10
72.90
175.80
1,025.00
1,509
Total Current Assets
5,967.60
11,090.90
7,223.00
21,982.10
17,554.00
27,587
Net Property, Plant & Equipment
467.30
339.50
372.80
644.70
746.00
794
Intangible Assets
3,193.20
2,580.10
1,901.90
1,251.90
648.00
352
Other Assets
9.00
-
-
-
900.00
-
Total Assets
9,637.10
14,010.50
9,497.70
23,878.70
19,848.00
39,133
ST Debt & Current Portion LT Debt
465.80
1,244.60
842.20
278.40
170.00
Accounts Payable
713.10
967.40
1,043.40
2,093.20
1,084.00
Income Tax Payable
11.90
-
-
-
184.00
Other Current Liabilities
962.80
1,045.20
1,191.30
2,068.10
2,674.00
Total Current Liabilities
2,153.50
3,257.20
3,076.90
4,439.70
4,112.00
Long-Term Debt
12,031.00
10,774.30
11,229.90
3,596.90
12,355.00
Total Liabilities
14,184.50
14,031.50
14,306.90
8,036.60
16,467.00
Common Equity (Total)
4,547.40
21.00
4,809.20
15,842.10
3,381.00
Total Shareholders' Equity
4,547.40
21.00
4,809.20
15,842.10
3,381.00
Total Equity
4,547.40
21.00
4,809.20
15,842.10
3,381.00
Liabilities & Shareholders' Equity
9,637.10
14,010.50
9,497.70
23,878.70
19,848.00

About Biofrontera

View Profile
Address
Hemmelrather Weg 201
Leverkusen Nordrhein-Westfalen 51377
Germany
Employees -
Website http://biofrontera.com
Updated 07/08/2019
Biofrontera AG is a biopharmaceutical company, which engages in the development, sale, and distribution of dermatological drugs and medical cosmetics for the care, protection, and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria, and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.